Inflammatory changes after cryosurgery-induced necrosis in human melanoma xenografted in nude mice

Journal of Investigative Dermatology

Volumn 116, Issue 5, 2001, Pages 664-671

  Gazzaniga, Silvina ^d   Bravo, Alicia ^a   Goldszmid, Silvana R ^b   Maschi, Fabricio ^d   Martinelli, Julio ^a   Mordoh, José ^b   Wainstok, Rosa ^c  

^a Hospital Eva Peron   (Argentina)

^b FUNDACIÓN INSTITUTO LELOIR   (Argentina)

^c Laboratorio de Optica   (Argentina)

^d NONE

Author keywords

Cryosurgery; Granulocyte monocyte colony stimulating factor; Inflammatory infiltrate; Melanoma

Indexed keywords

LIQUID NITROGEN; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ANIMAL CELL; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; CRYOSURGERY; CYTOTOXICITY; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNE RESPONSE; INFLAMMATION; INFLAMMATORY CELL; MELANOMA; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; TISSUE NECROSIS; TUMOR GROWTH; XENOGRAFT;

EID: 0035021109     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0022-202X.2001.01313.x     Document Type: Article

References (35)

1. Ballaré C, Barrio M, Portela P, Mordoh J: Functional properties of FC-2.15, a monoclonal antibody that mediates human complement cytotoxicity against breast cancer cells. Cancer Immunol Immunother 41:15-22, 1995
2. Bennett SR, Carbone FR, Karamalis F, Miller JF, Heath WR: Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell help. J Exp Med 186:65-70, 1997
3. Burgess A, Camakaris J, Metcalf D: Purification and properties of colony-stimulating factor from mouse lung-conditioned medium. J Biol Chem 252:1998-2003, 1977
4. x hapten. Cancer Immunol Immunother 45:334-339, 1998
5. Clynes R, Takechi Y, Moroi Y, Houghton A, Ravetch JV: Fc receptors are required in passive and active immunity to melanoma. Proc Natl Acad Sci USA 95:652-656, 1998
6. Cotran RS, Pober JS: Endothelial activation. Its role in inflammatory and immune reactions. In: Simionescu N, Simionescu M (eds). Endothelial Cell Biology. New York: Plenum, 1988, pp 335-347
7. Dong QG, Bemasconi S, Lostaglio S, et al: A general strategy for isolation of endothelial cells from murine tissues. Arterioscler Thromb Vasc Biol 17: 1997
8. Dranoff G, Jaffee A, Lazenby P, et al: Vaccination with irradiated tumor cells engineered to secrete human granulocyte-macrophage colony-stimulating factor stimulates potent, specific and long-lasting antitumor immunity. Proc Natl Acad Sci USA 90:3539, 1993
9. Gallucci S, Lolkema M, Matzinger P: Natural adjuvants: endogenous activator of dendritic cells. Nat Med 5:1249-1255, 1999
10. Guerra L, Mordoh J, Slavtsusky Y, Larripa Y, Medrano E: Characterization of IIB-Mel J. A new and highly heterogeneous human melanoma cell line. Pigment Cell Res 2:504-509, 1989
11. Hemberg M, Turunen J, Muhonen T, Pyrhönen S: Tumor infiltrating lymphocytes in patients with metastatic melanoma receiving chemoimmunotherapy. J Immunother 20:488-495, 1997
12. Hsu CK, Whitney RA, Hansen CT: Thymus-like lymph node in nude mice. Nature 257:681-682, 1975
13. Huang AY, Golumbek P, Ahmadzadeh M, Jaffee E, Pardoll D, Levitsky H: Role of bone marrow-derived cells in presenting MHC class I-restricted rumor antigens. Science 264:961-965, 1994
14. Kairiyama C, Slavutsky I, Larripa I, et al: Biologic immunocytochemical, and cytogenetic characterization of two new human melanoma cell lines: IIB-MEL-LES and IIB-MEL-IAN. Pigment Cell Res 8:121-131, 1995
15. Kimber I, Cumberbatch M, Dearman RJ, Bhushan M, Griffiths CE: Cytokines and chemokines in the initiation and regulation of epidermal Langerhans cell mobilization. Br J Dermatol 142:401-412, 2000
16. Klein C, Bueler H, Mulligan RC: Comparative analysis of genetically modified dendritic cells and tumor cells as therapeutic cancer vaccines. J Exp Med 191:1699-1708, 2000
17. Kushner BH, Cheung NK: GM-CSF enhances 3F8 monoclonal antibody-dependent cellular cytotoxicity against human melanoma and neuroblastoma. Blood 73:1936-1941, 1989
18. Mazur P: Freezing of living cells: Mechanisms and implications. Am J Physiol 247:125-142, 1984
19. Mongini PK, Paul WE, Metcalf ES: T cell regulation of immunoglobulin class expression in the antibody response to trinitrophenyl-ficoll. Evidence for T cell enhancement of the immunoglobulin class switch. J Exp Med 155:884-902, 1982
20. Morvillo V, Bover L, Mordoh J: Identification and characterization of 14 kDa immunosuppressive protein derived from IIB-MEL-L, a human melanoma cell line. Cell Mol Biol 42:779-795, 1996
21. Nasi ML, Lieberman P, Busam KJ, et al: Intradermal injections of granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with metastatic melanoma recruits dendritic cells. Cytokines Cell Mol Ther 5:139-144, 1999
22. Nooijen P, Eggermont A, Schalkwijk L, Henzen-Logmans S, de Waal R, Ruiter D: Complete response of melanoma-in-transit metastasis after isolated limb perfusion with tumor necrosis factor alpha and melphalan without massive tumor necrosis: a clinical and histopathological study of the delayed-type reaction pattern. Cancer Res 58:4880-4887, 1998
23. Orpwood RD: Biophysical and engineering aspects of cryosurgery. Phys Med Biol 26:555-575, 1981
24. Randolph GJ, Inaba K, Robbiani DF, Steinman RM, Muller WA: Differentiation of phagocytic monocytes into lymph node dendritic cells in vivo. Immunity 11:753-761, 1999
25. Sauter B, Alberta M, Franciscoa L, Larssona M, Somersana S, Bhardwaj N: Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J Exp Med 191:423-434, 2000
26. Shutt DC, Daniels KJ, Carolan EJ, Hill AC, Soll DR: Changes in the motility, morphology and F-actin architecture of human dendritic cells in an in vitro model of dendritic cell development. Cell Motil Cytoskeleton 46:200-221, 2000
27. Si Z, Hersey P, Coates AS: Clinical responses and lymphoid infiltrates in metastatic melanoma following treatment with intralesional GM-CSF. Melanoma Res 6:247-255, 1996
28. Soiffer R, Lynch M, Mihm M, et al: Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma. Proc Natl Acad Sci USA 95:13141, 1998
29. Soule HD, Vazquez J, Long A, Albert S, Brennan M: A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 51:1409-1415, 1973
30. Springer TA: Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76:301-314, 1994
31. Szabolcs P, Avigan D, Gezelter S, Ciocon DH, Moore MA, Steinman RM, Young JW: Dendritic cells and macrophages can mature independently form a human bone marrow-derived, post-colony-forming unit intermediate. Blood 87:4520-4530, 1996
32. Turk T, Rees M, Pietrow P, Myers C, Mills C, Gillenwater J: Determination of optimal freezing parameters of human prostate cancer in a nude mice model. Prostate 38:137-143, 1999
33. Wells A, Malkovsky M: Heat shock proteins, tumor immunogenicity and antigen presentation: an integrated review. Immunol Today 21:129-132, 2000
34. Wing EJ, Magee DM, Whiteside TL, Kalan SS, Shadduck RK: Recombinant human granulocyte/macrophage colony-stimulating factor enhances monocyte cytotoxicity and secretion of tumor necrosis factor alpha and interferon in cancer patients. Blood 73:643-646, 1989
35. Zouboulis ChC: Principles of cutaneous cryosurgery. An update. Dermatology 198:111-117, 1999